Skip to main content
[Preprint]. 2024 Jul 2:rs.3.rs-4619285. [Version 1] doi: 10.21203/rs.3.rs-4619285/v1

Figure 2: Rates of CRS and ICANS in all cohorts.

Figure 2:

(2A) Overall rate of CRS by grade. (2B) Rate of CRS by grade and by dose level of CAR T cells. (2C) Overall rate of ICANS by grade. (2D) Rate of ICANS by grade and by dose level of CAR T cells.

CRS denotes cytokine release syndrome; ICANS denotes immune effector-cell mediated neurotoxicity syndrome; DL denotes dose level.